Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats

Figure 2 Assessment of glycemic profiles. A-D: Measurement of serum glucose level (A), insulin level (B), Homeostasis Model Assessment of Insulin Resistance levels (C), glycated hemoglobin% (D) in the control group and other experimental groups. The data, presented as means ± SE (n = 6), indicate significant differences at P < 0.05. STZ: Streptozotocin; MET: Metformin; CHO: Cholecalciferol; TAU: Taurine; HbA1c: Glycated hemoglobin. ^aSignificance compared to the control group. ^bSignificance compared to the Streptozotocin diabetic group. ^cSignificance compared to the metformin-treated group.